Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers. (Q33384257)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

main subject

phase II clinical trial

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Afshin Dowlati

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

James Posey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ramesh K Ramanathan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Linda Rath

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Amitabh Chak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Smitha Krishnamurthi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Joanna Brell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Stephen Ingalls

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Charles L Hoppel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Percy Ivy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Scot C Remick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

28 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

73-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma

26 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

21 June 2018

Biliary tract cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

Optimal two-stage designs for phase II clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

Natural history study of gallbladder cancer: a review of 36 years experience at M. D. Anderson Hospital and Tumor Institute

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

Gemcitabine and Cisplatin Is a Highly Effective Combination Chemotherapy in Patients With Advanced Cancer of the Gallbladder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

Trends in incidence and management of gallbladder carcinoma: a population-based study in France

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4220168

10.1007/S00280-009-1005-X

31 October 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

26 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

19399502

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399502%20AND%20SRC:MED&resulttype=core&format=json